World's Best Scientists 2026 revealed!
Karl-Johan Malmberg

Karl-Johan Malmberg

Award Badge
Immunology
Norway
2026

D-Index & Metrics

Immunology

D-Index
71
Citations
18612
World Ranking
2312
National Ranking
12

Medicine

D-Index
71
Citations
18676
World Ranking
19988
National Ranking
108

Karl-Johan Malmberg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Karl-Johan Malmberg sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 209 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Karl-Johan Malmberg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Karl-Johan Malmberg sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Norway Leader Award
  • 2025 - Research.com Immunology in Norway Leader Award
  • 2022 - Research.com Immunology in Norway Leader Award

Overview

Karl-Johan Malmberg is affiliated with Oslo University Hospital in Norway and has contributed extensively to research in immunology and microbiology, with particular focus on immune cell function and interactions. Their work spans key areas such as CAR-T cell therapy, T-cell and B-cell immunology, immunotherapy, infectious diseases, oncology, and hematology.

The researcher has published frequently in respected venues including Blood, Regular and Young Investigator Award Abstracts, bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, and Science Immunology. Their collaborations include several frequent co-authors, reflecting an active network within the scientific community.

  • Ebba Sohlberg
  • Bahram Valamehr
  • Quirin Hammer
  • Eivind Heggernes Ask
  • Brian Groff

Karl-Johan Malmberg's recent notable publications cover vital topics around immune responses to infectious diseases and cancer immunology. Selected papers include:

  • "High-dimensional single-cell analysis of human natural killer cell heterogeneity," 2024, Nature Immunology
  • "Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19," 2020, Cell
  • "Natural killer cell immunotypes related to COVID-19 disease severity," 2020, Science Immunology
  • "Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity," 2020, Cell stem cell
  • "MAIT cell activation and dynamics associated with COVID-19 disease severity," 2020, Science Immunology

The main fields of study Karl-Johan Malmberg is involved in include:

  • Immunology and Microbiology
  • Medicine

Their work also delves deeper into subfields such as:

  • Immunology
  • Oncology
  • Molecular Biology
  • Infectious Diseases
  • Hematology

Key research topics addressed by Karl-Johan Malmberg are:

  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • T-cell and B-cell Immunology
  • Immunotherapy and Immune Responses
  • COVID-19 Clinical Research Studies
  • Immune cells in cancer
  • Hematopoietic Stem Cell Transplantation

Best Publications

  • Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

    K Malmberg;Lars Rydén;H Wedel;K Birkeland

  • Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education

    Niklas K. Björkström;Peggy Riese;Frank Heuts;Sandra Andersson

  • Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.

    Heinrich Schlums;Frank M Cichocki;Frank M Cichocki;Bianca Tesi;Jakob Theorell

  • Prospects for the use of NK cells in immunotherapy of human cancer

    Hans-Gustaf Ljunggren;Karl-Johan Malmberg

  • NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRS

    Vivien Béziat;Lisa L. Liu;Jenny-Ann Malmberg;Martin A. Ivarsson

  • Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus

    Niklas K. Björkström;Therese Lindgren;Malin Stoltz;Cyril Fauriat;Cyril Fauriat

  • Natural killer cell immunotypes related to COVID-19 disease severity.

    Christopher Maucourant;Iva Filipovic;Andrea Ponzetta;Soo Aleman;Soo Aleman

  • Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.

    M Bartnik;K Malmberg;A Norhammar;A Tenerz

  • Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.

    A M Norhammar;L Rydén;K Malmberg

  • Education of human natural killer cells by activating killer cell immunoglobulin-like receptors

    Cyril Fauriat;Martin A. Ivarsson;Hans-Gustaf Ljunggren;Karl-Johan Malmberg

  • CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

    Vivien Béziat;Vivien Béziat;Vivien Béziat;Olav Dalgard;Tarik Asselah;Philippe Halfon

  • CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.

    Julia A. Wagner;Maximillian Rosario;Rizwan Romee;Melissa M. Berrien-Elliott

  • Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity.

    Huang Zhu;Robert H. Blum;Davide Bernareggi;Eivind Heggernes Ask

  • Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.

    Mattias Carlsten;Håkan Norell;Yenan T. Bryceson;Isabel Poschke

  • DNAX Accessory Molecule-1 Mediated Recognition of Freshly Isolated Ovarian Carcinoma by Resting Natural Killer Cells

    Mattias Carlsten;Niklas K. Björkström;Håkan Norell;Yenan Bryceson

  • Natural killer cell-mediated immunosurveillance of human cancer.

    Karl-Johan Malmberg;Mattias Carlsten;Andreas Björklund;Ebba Sohlberg

  • Diabetes mellitus and congestive heart failure. Further knowledge needed.

    L. Soläng;K. Malmberg;L. Rydén

  • IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

    Karl Johan Malmberg;Victor Levitsky;Håkan Norell;Cristina Teixeira De Matos

  • Role for early-differentiated natural killer cells in infectious mononucleosis

    Tarik Azzi;Tarik Azzi;Anna Lünemann;Anna Lünemann;Anita Murer;Seigo Ueda;Seigo Ueda;Seigo Ueda

  • Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C- Deficient Humans

    Lisa L. Liu;Johannes Landskron;Eivind H. Ask;Eivind H. Ask;Monika Enqvist

  • Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas.

    Yang Rongcun;Flavio Salazar-Onfray;Jehad Charo;Karl Johan Malmberg

Frequent Co-Authors

Hans-Gustaf Ljunggren
Hans-Gustaf Ljunggren Karolinska Institute
Niklas K. Björkström
Niklas K. Björkström Karolinska University Hospital
Jeffrey S. Miller
Jeffrey S. Miller University of Minnesota
Jakob Michaëlsson
Jakob Michaëlsson Karolinska University Hospital
Dan S. Kaufman
Dan S. Kaufman University of California, San Diego
Rolf Kiessling
Rolf Kiessling Karolinska Institute
Yenan T. Bryceson
Yenan T. Bryceson Karolinska Institute
Johan K. Sandberg
Johan K. Sandberg Karolinska University Hospital
Per Ljungman
Per Ljungman Karolinska University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related online degrees can open doors to diverse healthcare careers. Many nursing professionals seek advanced qualifications, and programs like the cheapest pmhnp programs online offer affordable pathways to become psychiatric nurse practitioners. These programs combine flexible learning with specialized skills relevant to mental health.

Understanding compensation is also vital when planning a career. Transparent data such as the dnp salary transparency resource helps candidates assess the financial prospects of pursuing a Doctor of Nursing Practice degree across different states.

For nurses aiming to specialize further, bridge programs play a crucial role. Transitioning from a Family Nurse Practitioner to acute care roles can be streamlined through the fnp to acute care np bridge program, which provides targeted education to handle more complex patient care scenarios.

Additionally, those looking to accelerate their entry into advanced practice can benefit from the accelerated np program. These options fast-track nursing careers while maintaining rigorous academic standards, making them attractive to motivated students and professionals alike.

Best Scientists Citing Karl-Johan Malmberg

Trending Scientists

Recently Published Articles